PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Iyer KS, Marks GA, Kastin AJ, McCann SM
Client retention excellence: Visible results create loyal clients who return monthly for maintenance treatments indefinitely
Everything you need for your research, delivered right to your door
No Synthetic Fillers: Avoid products with unnecessary sugars, artificial colors, or synthetic preservatives
Certain symptoms that indicate you should seek care ASAP: severe pain sudden weakness joint swelling fever blood in the stool unexplained weight loss symptoms that dont go away or worsen with time Midlife changes are real, often confusing, and typically frustrating